-
Track & Monitor
Merger and Acquisition Trends in Pharma - Q2 2026
This report analyzes the merger and acquisition (M&A) activity in Q2 2026 in the Pharma sector.
-
Track & Monitor
Venture Capital Investment Trends in Pharma - Q2 2026
This report analyzes the venture capital (VC) investment activity in Q2 2026 in the Pharma sector.
-
Sector Analysis
Emerging Market Outsourcing Report, Q2 2026
Report Value Proposition – Why Does Pharma Outsourcing Matter? Pharmaceutical outsourcing continues to play a critical role in helping drug manufacturers improve efficiency, reduce costs, and accelerate product development. As emerging markets expand their manufacturing capabilities, contract manufacturing organizations (CMOs) are becoming increasingly important partners across active pharmaceutical ingredient (API) production, biologics, drug formulation, packaging, and commercial manufacturing. GlobalData's Emerging Pharma Market Outsourcing report provides a comprehensive analysis of pharmaceutical manufacturing trends across emerging markets, with a particular focus on...
-
Sector Analysis
Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape
This report provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis (FSGS) Therapeutics. In 2025, there were 37,049 incident cases of FSGS in the 16 countries covered in GlobalData’s epidemiology forecast. In 2021, the most recent guideline for physicians for diagnosis and treatment of FSGS was established across seven major markets (US, France, Germany, Italy, Spain, the UK, and Japan) by the Kidney Disease Improving Global Outcomes (KDIGO). Over roughly the past three years,...
-
Consumer Insights
Industry Insights: How Dietary Supplements Have Evolved Beyond Traditional Health Management
This report highlights the shift in consumer preferences from traditional health supplements to modern formats designed to address specific health needs. As people become more health-conscious, they are increasingly seeking tailored, localized products that support longevity and overall vitality. Growing interest in these contemporary supplements is largely fueled by online marketing and easier access to health information through social media. The report explores consumer interest in nootropics, nutricosmetics, and cellular health supplements. As health and wellness become a higher priority...
-
Sector Analysis
IgA Nephropathy (Berger’s Disease): Market View, Current and Future Competitive Landscape
This report provides a data-driven overview of the current and future competitive landscape in IgA Nephropathy (Berger’s Disease) Therapeutics. • In 2025, there were 102,155 incident cases of Berger's disease in the 16 countries covered in GlobalData’s epidemiology forecast. • Berger's disease is primarily managed with blood pressure medication like ACE inhibitors or ARBs to protect the kidneys. For high-risk patients, corticosteroids and newer targeted therapies are also available to slow the disease's progression. • The Berger's disease pipeline holds...
-
Sector Analysis
Reflux Esophagitis (Gastroesophageal Reflux Disease): Market View, Current and Future Competitive Landscape
This report provides a data-driven overview of the current and future competitive landscape in Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics. In 2025, there were 308.98 million 12- month total diagnosed prevalent cases of GERD in the 16 countries covered in GlobalData’s epidemiology forecast. The management of GERD typically includes a mix of lifestyle adjustments, medication-based treatments, and, in certain cases, surgical or procedural options. Key therapy classes showing this effect include PPIs, histamine H2 receptor (HRH2) antagonists, and dopamine receptor...
-
Sector Analysis
Postpartum Depression (PPD): Market View, Current and Future Competitive Landscape
This report provides a data-driven overview of the current and future competitive landscape in Postpartum Depression (PPD) Therapeutics. In 2025, there were 10.89 million prevalent cases of PPD across the 16 countries covered in GlobalData’s epidemiology forecast. PPD is typically managed with psychotherapy (CBT or interpersonal therapy) and antidepressants, most commonly SSRIs, tailored to breastfeeding considerations and patient preferences, alongside practical supports such as sleep and family assistance. For moderate-to-severe illness, faster-acting neuroactive steroid treatments include IV brexanolone (a 60-hour...
-
Sector Analysis
Overweight and Obesity: Epidemiology Report and Forecast to 2035
Obesity is a chronic disease characterized by the accumulation of excess body fat. Individuals living with obesity may undergo metabolic dysfunction on account of excess adipose tissue. The diagnostic criteria for obesity are met by a body mass index (BMI) of 30kg/m2 or more (NIH, 2022a). This can lead to a state of chronic systemic inflammation, as well as a predisposition to comorbidities such as diabetes and cardiovascular disease. Clinical interventions aim to manage obesity by encouraging patient behavioral change,...
-
Sector Analysis
Hepatocellular Carcinoma (HCC): Epidemiology Report and Forecast to 2035
Hepatocellular carcinoma (HCC) arises from the hepatocyte cells in the liver and is the most common primary liver cancer, accounting for approximately 90% of all primary cancers of the liver (Asafo-Agyei and Samant, 2023). HCC has a high mortality rate and is the third leading cause of cancer deaths annually worldwide (Singal, Kanwal and Llovet, 2023). Major risk factors for HCC include infection with the hepatitis B virus (HBV), infection with the hepatitis C virus (HCV), and high alcohol consumption...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.